新的抗真菌药物、免疫调节疗法和多种联合治疗方案的出现，使得侵袭性曲霉病患者的存活率有了显著提升。
With the emergence of new antifungal agents, immunomodulation intervention and combination therapy, the survival rate of patients with invasive aspergillosis has been improved greatly.
目的：侵袭性淋巴瘤的主要致死原因是复发或对初始疗法无应答。
PURPOSE: The major cause of death in aggressive lymphoma is relapse or nonresponse to initial therapy.
我们在此报道一个II期多中心单一研究项试验，以评价来那度胺口服单一疗法治疗复发性或难治性侵袭性NHL的安全性和有效性。
We report the results of a phase II, single-arm, multicenter trial evaluating the safety and efficacy of lenalidomide oral monotherapy in patients with relapsed or refractory aggressive NHL.
应用推荐